Streetbeat News

Products Services

F

TSLA

As Tesla's Cybertruck Delivery Event approaches, a leaked picture shows three high-powered outlets in the Cybertruck's bed, capable of charging other electric vehicles at high speed. This feature is seen as a comparison to Ford's F-150 Lightning, which also includes power outlets. However, recent leaks of the Cybertruck's front trunk have not shown any outlets like those in the Ford F-150 Lightning.

Portfolio Pulse from Benzinga EV Insights

November 08, 2023 | 5:35 pm

XRPUSD

Ripple has upgraded its payments platform to expand its business interests in the U.S. and Africa. The new platform, Ripple Payments, targets corporate clients in the U.S. with cross-border payments solutions. The company also announced a partnership with African fintech Onafriq to facilitate cross-border crypto payments between Africa and other markets. Ripple's XRP token price has rallied 37% in the past month.

Portfolio Pulse from Khyathi Dalal

November 08, 2023 | 5:26 pm

LLY

The U.S. Food and Drug Administration has approved Zepbound, a medication for chronic weight management in adults with obesity or overweight. The drug, developed by Eli Lilly and Co., has been proven effective in two randomized, double-blind, placebo-controlled trials. However, the FDA warns that the safety and effectiveness of coadministration of Zepbound with other medications for weight management have not been established. Zepbound also carries warnings for several potential side effects, including pancreatitis, gallbladder problems, hypoglycemia, acute kidney injury, and diabetic retinopathy.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 5:17 pm

DRRX

Durect Corporation's shares are trading lower after the company announced that its Phase 2B AHFIRM trial did not achieve statistical significance for either dose on the primary endpoint of mortality or transplant at 90 days.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 5:06 pm

GOOG

Google has announced an expansion of its partnership with AI safety and research startup Anthropic. The partnership includes collaborations on AI safety standards and AI security, and Anthropic will use Google's Cloud TPU v5e chips for AI inference. Anthropic has built one of the largest Google Kubernetes Engine clusters and uses Google's AlloyDB and BigQuery. Anthropic is also using Google Cloud's security services, including Chronicle Security Operations, Secure Enterprise Browsing, and Security Command Center. Anthropic is one of the first companies to deploy at scale TPU v5e, Google Cloud's most versatile, efficient, and scalable AI accelerator.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 5:04 pm

SFIX

Stitch Fix has hired Tony Bacos, a former Amazon Fashion executive, as its new Chief Product and Technology Officer. Bacos will lead the company's technology, product, data science, security, and IT teams, with a focus on utilizing data science and stylist expertise to improve personalization efforts and unlock new growth opportunities. This move comes as Stitch Fix continues to struggle financially, with a 21% year-over-year net revenue decrease and a 13% drop in active clients for fiscal 2023.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 4:54 pm

AMGN

Amgen Inc has released new data from its Phase 2 study of dazodalibep for Sjögren's syndrome, a chronic autoimmune disorder. The study showed that patients who transitioned from placebo to dazodalibep experienced an improvement in their disease activity and symptoms. The drug was generally safe and well tolerated.

Portfolio Pulse from Vandana Singh

November 08, 2023 | 4:43 pm

DRRX

DURECT Corporation (NASDAQ:DRRX) released topline results from its AHFIRM Phase 2b study of larsucosterol in patients with severe alcohol-associated hepatitis (AH). The results did not achieve statistical significance for the primary endpoint of mortality or transplant at 90 days. However, both doses of larsucosterol showed a clinically meaningful trend in reduction of mortality at 90 days. DURECT plans to discuss the trial results and the Phase 3 registration trial design with the FDA in Q1 2024. DRRX shares are down 75.90% at $0.62.

Portfolio Pulse from Vandana Singh

November 08, 2023 | 4:38 pm

STLA

Stellantis (STLA) is seeking innovative solutions to production challenges through its Factory Booster Day event. The company invited 64 suppliers and startups to present solutions to 35 identified challenges, with the aim of reducing CO2 emissions, improving product quality, and decreasing costs. The event aligns with the company's Dare Forward 2030 strategic plan, which includes becoming a carbon net zero corporation by 2038 and reducing production costs by 40% by 2030.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 4:38 pm

PMBHF

PharmAla Biotech (OTC:PMBHF) is set to ship the first of several batches of psychedelic molecules, including MDMA and psilocybin, to its Australian JV Cortexa for use under the Authorized Prescriber Scheme (APS). This marks the first time any molecules recently re-scheduled under Australia’s APS are imported for use under that scheme, rather than for clinical trials. PharmAla's CEO Nick Kadysh believes Cortexa will become the industry leader in the import, sale, and distribution of psilocybin and MDMA for medical purposes.

Portfolio Pulse from Lara Goldstein

November 08, 2023 | 4:35 pm